Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- AMBACHE N. Further studies on the preparation, purification and nature of irin. J Physiol. 1959 May 19;146(2):255–294. doi: 10.1113/jphysiol.1959.sp006193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BRODIE B. B., SHORE P. A. A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann N Y Acad Sci. 1957 Mar 14;66(3):631–642. doi: 10.1111/j.1749-6632.1957.tb40753.x. [DOI] [PubMed] [Google Scholar]
- FELDBERG W., SHERWOOD S. L. Injections of drugs into the lateral ventricle of the cat. J Physiol. 1954 Jan;123(1):148–167. doi: 10.1113/jphysiol.1954.sp005040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GEIGER A., YAMASAKI S. Cytidine and uridine requirement of the brain. J Neurochem. 1956 Dec;1(2):93–100. doi: 10.1111/j.1471-4159.1956.tb12059.x. [DOI] [PubMed] [Google Scholar]
- KIRSCHNER H., VOGT W. [Pharmacologically active lipidsoluble acids in brain extracts: isolation of lysophosphatidic acid and ganglioside]. Biochem Pharmacol. 1961 Sep;8:224–234. doi: 10.1016/0006-2952(61)90005-3. [DOI] [PubMed] [Google Scholar]
- SCHMITZ H., POTTER V. R., BURLBERT R. B., WHITE D. M. Alternative pathways of glucose metabolism. II. Nucleotides from the acid-soluble fraction of normal and tumor tissues and studies on nucleic acid synthesis in tumors. Cancer Res. 1954 Jan;14(1):66–74. [PubMed] [Google Scholar]
- TOH C. C., MOHIUDDIN A. Vasoactive substances in the nasal mucosa. Br J Pharmacol Chemother. 1958 Jun;13(2):113–117. doi: 10.1111/j.1476-5381.1958.tb00204.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- VOGT W. Naturally occurring lipidsoluble acids of pharmacological interest. Pharmacol Rev. 1958 Sep;10(3):407–435. [PubMed] [Google Scholar]